Grant brings nearly 40 years of agricultural and corporate leadership, including as Chairman, President, and Chief Executive Officer of the former Monsanto Company, a global provider of technology-bas...
Invaio Sciences, Inc. today announced the closing of a Series C financing round totaling $88.9 million. Joining founder and principal backer Flagship Pioneering is Stage 1 Ventures, Bluwave Capital, ...
Invaio Sciences announced today an agreement with the world-renowned Fundecitrus, Fund for Citrus Protection, located in Araraquara, Brazil. The agreement focuses on the collaboration to evaluate the...
Invaio Sciences, Inc. announced today the appointment of Peleg Chevion as President and Chief Commercial Officer. Chevion, who joined the company in late 2020, will focus on accelerating the commerci...
Invaio Sciences, Inc. announces today the appointment of new academic leaders as members to its Scientific Advisory Board (SAB). ...
Invaio Sciences, Inc. announces today the appointment of three new industry leading members to its Board of Directors. Dr. Pietro Antonio Tataranni is Chief Medical Officer at PepsiCo, Ena Cratsenbur...
Invaio Sciences, Inc. today announced a new, exclusive world-wide license agreement with the University of California (UC-Riverside) for a novel technology developed by Professor Hailing Jin at the Un...
Flagship Pioneering, a unique life sciences innovation enterprise, today announced the unveiling of Invaio Sciences, a technology company that unlocks the potential of the planet’s interdependent na...